Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies



Status:Recruiting
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:1/26/2018
Start Date:March 15, 2017
End Date:March 2023
Contact:Ziding Feng, PHD
Email:CR_Study_Registration@mdanderson.org
Phone:713-563-4276

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies - PROCEED Study

The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible
for the coordination and data management for the Prospective Evaluation of Chronic
Pancreatitis for Epidemiologic and Translational Studies (PROCCEED) Study, which is part of
the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic
Cancer (CPDPC). No patient enrollment will occur at MDACC. All patient recruitment will occur
at external sites that are a part of the CPDPC. The data management systems, auditing, and
monitoring effort are supported by the MD Anderson Cancer Center Clinical Research Support
Center (CRSC).


Inclusion Criteria:

1. Participants with chronic pancreatitis.

Exclusion Criteria:
We found this trial at
1
site
University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials